Treatment of massive submacular haemorrhage with subretinal tissue plasminogen activator and pneumatic displacement

Research output: Contribution to journalMeeting abstract

1 Citation (Scopus)

Abstract

Purpose: To present a video of a massive submacular haemorrhage successfully treated with subretinal tissue plasminogen activator and pneumatic displacement.

Methods: Video case presentation.

Results: An 80-year-old pseudophakic Caucasian lady was being successfully treated for neovascular age-related macular degeneration in her left eye with a visual acuity of 6/9 after two monthly injections of intravitreal ranibizumab. One week before her third injection, she presented with acute painless central vision loss in that eye. Visual acuity was reduced to hand motions and a large submacular haemorrhage extending to the vascular arcades was detected. The location of the blood was confirmed to be subretinal by optical coherence tomography and fundus autofluorescence. Urgent 25-gauge three-port pars plana vitrectomy was performed with subretinal injection of the recombinant tissue plasminogen activator tenecteplase (Metalyse®). A partial fluid–air–gas (20% sulfur hexafluoride) exchange was performed. Postoperatively, the patient was postured at 45° face down for 3 days. Two weeks postoperatively, almost all the subretinal haemorrhage had been displaced to the far inferior retina and the visual acuity had improved back to 6/24.

Conclusion: Subretinal injection of tissue plasminogen activator combined with pneumatic displacement can be used to successfully treat massive submacular haemorrhages.
Original languageEnglish
Article number16
Pages (from-to)77
Number of pages1
JournalClinical and Experimental Ophthalmology
Volume43
Issue numberSupplement 1
Publication statusPublished - Oct 2015
EventAnnual Scientific Congress of the Royal Australian and New Zealand College of Ophthalmologists (47th : 2015) - Wellington, New Zealand
Duration: 31 Oct 20154 Nov 2015

Cite this